Teva Pharmaceuticals USA has introduced Terazosin HCl capsules, 1 mg, 2 mg, 5 mg and 10 mg. The product, indicated for treatment of benign prostatic hyperplasia as well as hypertension, is bioequivalent to and therapeutically interchangeable with Hytrin (terazosin HCl) capsules. All capsule strengths are available in bottles of 100.
COPYRIGHT 2000 Lebhar-Friedman, Inc.
COPYRIGHT 2000 Gale Group